Latest Breaking News On - Punit patel - Page 1 : vimarsana.com

Which Is The Largest Pharma Company In India | Top 10 Pharmaceutical Companies By Market Cap In India

Which Is The Largest Pharma Company In India | Top 10 Pharmaceutical Companies By Market Cap In India
forbesindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbesindia.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshUnited statesKallam anji reddySanjay chaturvediPunit patelUmang vohraPenaka venkata ramprasad reddyKhwaja abdul ahmeidAurobindo pharmaDilip shanghviSun pharmaKambam nithyananda reddyRamanbhaib patelChirag patelVinitad guptaEli lilly

Zydus Lifesciences introduces new drug in US markets

According to IQVIA MAT data, Mirabegron extended-release tablets (USP 25mg and 50mg) had yearly sales of USD 2.42 billion in the United States.

United statesZydus lifesciencesPunit patelCadila healthcareOveractive bladderAhmedabad special economic zoneZydus americasLifesciences limitedCadila healthcare limited

Zydus Lifesciences launches generic drug for overactive bladder in US market

The company has launched Mirabegron extended-release tablets in strength of 25 mg in the US market after having received final approval from the US Food and Drug Administration (USFDA), Zydus Lifesciences said in a regulatory filing.

Zydus lifesciencesPunit patelDrug administrationOveractive bladderUs market

Zydus Lifesciences introduces generic treatment for overactive bladder in the United States

Zydus Lifesciences introduces generic treatment for overactive bladder in the United States
devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.

Punit patelZydus lifesciencesDrug administrationOveractive bladder

Zydus launches Mirabegron Extended-Release Tablets in the US

Zydus Lifesciences Limited announces the launch of Mirabegron Extended-Release Tablets, 25 mg in the US market. The company had earlier received final approval from the United States Food and Drug.

United statesPunit patelDrug administrationZydus lifesciences ltdZydus groupZydus lifesciencesZydus lifesciences limitedMirabegron extended release tabletsUnited states foodExtended release tablets